Gp Capt Dr LS Rajeev Pagoda - PowerPoint presentation.pptx

rajeev433225 12 views 25 slides Jul 31, 2024
Slide 1
Slide 1 of 25
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18
Slide 19
19
Slide 20
20
Slide 21
21
Slide 22
22
Slide 23
23
Slide 24
24
Slide 25
25

About This Presentation

Thematic study on micro-nutrients


Slide Content

Can Trace Minerals Tame High Blood Sugar? Unveiling the Potential of Vanadium and Chromium in Diabetes Management L.S.R Pagoda1#, M.S.D Costa, and P.M.P.D.A Pagoda

Introduction: Diabetes mellitus, a chronic condition characterized by deficient insulin action and persistent hyperglycemia, casts a long shadow across the globe. Despite established therapeutic strategies, optimal glycemic control remains elusive, prompting exploration of alternative and complementary approaches.

This review delves into the intriguing therapeutic potential of vanadium and chromium, trace minerals with fascinating effects on insulin signaling and glucose metabolism, as modulators of glycemic control in diabetes.

Aim: Our aim is to systematically analyze the current evidence base and synthesize research findings concerning the mechanisms of action, clinical efficacy, and safety of vanadium and chromium in managing diabetes. By dissecting their intricate workings and clinical impact, we hope to illuminate their potential role in the diabetes management toolkit.

By dissecting their intricate workings and clinical impact, we hope to illuminate their potential role in the diabetes management toolkit .

Methodology: We embarked on a comprehensive search of relevant databases, employing keywords like "diabetes," "vanadium," "chromium," "insulin signaling," "glycemic control," and "thematic review."

Studies published in peer-reviewed journals, with a primary focus on vanadium and chromium supplementation in human subjects with diabetes, were meticulously scrutinized. Extracted data was critically appraised and categorized into key thematic areas for focused analysis.

Results: This thematic review sheds light on the multifaceted tapestry woven by vanadium and chromium in enhancing glucose metabolism. Vanadium, the insulin mimic, stimulates tyrosine phosphorylation and translocation of GLUT4 glucose transporters, mimicking insulin's action and ushering glucose into cells.

Chromium, the insulin potentiator , optimizes insulin receptor function and insulin-mediated glucose uptake, amplifying the body's response to this crucial hormone. Vanadium, while boasting robust insulin-mimicking properties, comes with a cautionary note. Potential side effects like nausea and diarrhea necessitate cautious administration and rigorous dose monitoring.

Clinical trials, however, present a nuanced picture of their effectiveness in improving glycemic control in type 2 diabetes. While some studies showcase a promising reduction in blood sugar levels, others paint a less optimistic picture. Factors like dosage, duration of treatment, and individual response appear to significantly influence therapeutic outcomes.

Chromium, on the other hand, exhibits a safer profile but its efficacy warrants further investigation, particularly regarding optimal dosage regimens.

Discussion: This review unveils the intriguing potential of vanadium and chromium as adjunctive strategies for diabetes management. Vanadium's potent insulin-mimicking properties warrant further exploration, but safety concerns demand careful consideration.

Chromium, with its safer profile, offers a promising avenue for research, requiring optimization of dosage and confirmation of its true efficacy. Future research should prioritize personalized medicine approaches to determine the most effective therapeutic strategies for individual patients.

Additionally, exploring the potential benefits of vanadium and chromium beyond glycemic control, such as improving lipid metabolism and mitigating oxidative stress, holds immense promise. By elucidating the complex interplay between these trace minerals and insulin signaling, this review paves the way for their potential inclusion in the diabetes management toolbox, ultimately aiming to improve health outcomes for millions grappling with this chronic condition.

Vanadium, the insulin mimic: This highlights the core function of vanadium in mimicking insulin's role in regulating blood sugar. Stimulates tyrosine phosphorylation: Vanadium interacts with cellular processes, triggering the phosphorylation (attachment of a phosphate group) of tyrosine residues on specific proteins. This phosphorylation is a crucial step in insulin signaling.

Translocation of GLUT4 glucose transporters: Vanadium promotes the movement of GLUT4 transporters, which are responsible for transporting glucose from the bloodstream into cells, to the cell membrane. This allows for increased glucose uptake. Mimicking insulin's action and ushering glucose into cells: By stimulating these processes, vanadium essentially replicates the actions of insulin, ultimately facilitating the entry of glucose into cells, which helps regulate blood sugar levels.

Chromium, the insulin potentiator : This emphasizes chromium's function in enhancing the body's response to insulin. Optimizes insulin receptor function: Chromium helps ensure that insulin receptors on cell surfaces are functioning optimally, allowing them to effectively bind with insulin molecules. Insulin-mediated glucose uptake: This refers to the process by which insulin binding triggers the uptake of glucose from the bloodstream into cells.

Amplifying the body's response to this crucial hormone: By improving insulin receptor function and glucose uptake, chromium essentially amplifies the body's natural response to insulin, leading to better blood sugar control.

Insulin Signaling: Normally, insulin binds to insulin receptors on cell surfaces. This triggers a cascade of events within the cell. Tyrosine Phosphorylation: One of the early steps involves the phosphorylation (attachment of a phosphate group) of tyrosine residues on specific proteins. Vanadium is believed to play a role in stimulating this phosphorylation process, mimicking insulin's action.

GLUT4 Translocation: Following tyrosine phosphorylation, there's a movement of GLUT4 transporters from internal compartments within the cell to the cell membrane. These GLUT4 transporters are responsible for transporting glucose from the bloodstream into the cell.

Vanadium is thought to promote this translocation of GLUT4 transporters. Increased Glucose Uptake: With more GLUT4 transporters on the cell membrane, the cell's capacity for glucose uptake is enhanced. This allows for better regulation of blood sugar levels.

Conclusion : The exact mechanism of vanadium's effect on the GLUT4 pathway is still under investigation. Vanadium may interact with other proteins or cellular processes besides tyrosine phosphorylation to influence GLUT4 translocation. The effectiveness of vanadium in mimicking insulin and promoting glucose uptake may vary depending on factors like dosage and individual response.

Critically assess the potential and limitations of vanadium and chromium as complementary strategies for diabetes management. Provide recommendations for future research and clinical practice, emphasizing the need for further investigation and personalized treatment approaches.
Tags